Current status and future directions of anti-angiogenic therapy for gliomas

Abstract. Molecular targets for the pathological vasculature are the vascular endothelial growth factor (VEGF)/VEGF receptor axis, integrins, angiopoietins, an

Saved in:

Bibliographic Details
Main Authors:	Wick, Wolfgang (Author) , Platten, Michael (Author) , Wick, Antje (Author) , Berberich, Anne (Author) , Radbruch, Alexander (Author) , Bendszus, Martin (Author) , Winkler, Frank (Author)
Format:	Article (Journal)
Language:	English
Published:	2016
In:	Neuro-Oncology Year: 2015, Volume: 18, Issue: 3, Pages: 315-328
ISSN:	1523-5866
DOI:	10.1093/neuonc/nov180
Online Access:	Verlag, Volltext: https://doi.org/10.1093/neuonc/nov180 Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/18/3/315/2509235
Author Notes:	Wolfgang Wick, Michael Platten, Antje Wick, Anne Hertenstein, Alexander Radbruch, Martin Bendszus, and Frank Winkler

Description
Summary:	Abstract. Molecular targets for the pathological vasculature are the vascular endothelial growth factor (VEGF)/VEGF receptor axis, integrins, angiopoietins, an
Item Description:	Advance Access date 12 October 2015 Gesehen am 11.03.2020
Physical Description:	Online Resource
ISSN:	1523-5866
DOI:	10.1093/neuonc/nov180